Clinical Trials
4 trialsNCT07575230 2026-05-11
Suzetrigine vs Norco-postoperative Mohs Pain
Baylor Research Institute
Phase 4 Enrolling by invitation
NCT07459543 2026-03-09
A Study To Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Untreated, Unresectable or Metastatic Melanoma Participants In India
Bristol-Myers Squibb
Phase 4 Not yet recruiting
NCT07426484 2026-02-23
Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Dana-Farber Cancer Institute
Phase 4 Not yet recruiting
NCT07200544 2025-12-15
Meloxicam in Mohs Micrographic Surgery
University of Oklahoma
Phase 4 Recruiting